mesowatch
FDA Approves Pembrolizumab with Chemotherapy for Advanced Mesothelioma
divider

FDA Approves Pembrolizumab with Chemotherapy for Advanced Mesothelioma

FDA Approves Pembrolizumab with Chemotherapy for Advanced Mesothelioma

Amna Anees

Reading Time: 2 mins

Published On: September 23, 2024

Amna Anees - author

Amna is a molecular biologist and has a deep interest in the field of health and medicine. She has worked in the field of proteomics and plants molecular biology. Being a biologist herself, she has developed an interest in the field of therapeutic studies of mesothelioma and related researches.

More to Read

divider

September 20, 2024

J&J Subsidiary Declares Bankruptcy to Push Forward $10 Billion Talc Settlement

divider

News & Data

Section divider

FILTER:

Search
Bottom divider

Browse Categories

divider
mesowatch

Mesowatch serves as an industry watchdog and advocates for patients and families affected by asbestos by providing reliable and up-to-date news stories and information on asbestos and mesothelioma.

NAVIGATE

About UsEditorial GuidelinesNewsSupport and ResourcesPrivacy Policy

CONTACT US

Email: support@mesowatch.com

Phone: (866) 402-1000

Address: 3260 N Hayden Rd, Suite 210, Scottsdale, AZ 85251

Copyright © 2024 by Mesowatch. All Rights Reserved.
The content on this website is protected by law and provided for informational purposes only. It is not intended as a substitute for professional medical or legal advice. Always seek advice from qualified professionals for health or legal matters.Disclaimer